1-8 of 8
Sarah Rutherford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The influence of age on patient-reported outcomes (PROs) endpoints on the S1826 cross-network Phase III trial of advanced-stage, classic Hodgkin lymphoma (cHL)

Free
Kelly Davison, Joseph Unger, Hongli Li, Sharon Castellino, Hildy Dillon, Tricia Hernandez, Sarah Rutherford, Angela Punnett, Michael LeBlanc, Joo Song, Sonali Smith, Andrew Evens, Kara Kelly, Jonathan Friedberg, Alex Herrera, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 2738.
https://doi.org/10.1182/blood-2025-2738
Published: 2025
Journal Articles

Precise-HL trial: Personalized reduction of chemotherapy intensity through ctdna evaluation in advanced Hodgkin lymphoma

Free
Ryan Lynch, David Russler-Germain, Joseph Schroers-Martin, Alison Moskowitz, Reid Merryman, Azra Borogovac, Hongyan Du, Heather Rasmussen, Ranjana Advani, Ash Alizadeh, Philippe Armand, Nancy Bartlett, Alex Herrera, Matthew Mei, Sarah Rutherford, David Kurtz, Ted Gooley, Jenna Voutsinas, Ajay Gopal
Journal: Blood
Blood (2025) 146 (Supplement 1): 5408.
https://doi.org/10.1182/blood-2025-5408
Published: 2025
Journal Articles

Interim and end-of-treatment FDG-PET demonstrate limited ability to predict 3-year progression-free survival with nivolumab-AVD in first-line treatment of advanced stage Hodgkin lymphoma: Imaging sub-analysis of Phase 3 S1826 study

Free
Nancy Bartlett, Hongli Li, Michael Knopp, Chad Wright, Heiko Schoder, Lawrence Schwartz, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Angela Punnett, Margaret Shipp, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Lale Kostakoglu, Kara Kelly, Michael LeBlanc, Jonathan Friedberg, Alex Herrera
Journal: Blood
Blood (2025) 146 (Supplement 1): 1851.
https://doi.org/10.1182/blood-2025-1851
Published: 2025
Journal Articles

Clinical prognostication in the SWOG 1826 randomized clinical trial of nivolumab-AVD versus brentuximab-AVD: Performance of the advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI)

Free
Carla Casulo, Hongli Li, Alex Herrera, Sharon Castellino, Sarah Rutherford, Kelly Davison, Angela Punnett, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg, Michael Leblanc, Susan Parsons, Angie Mae Rodday, Andrew Evens
Journal: Blood
Blood (2025) 146 (Supplement 1): 154.
https://doi.org/10.1182/blood-2025-154
Published: 2025
Journal Articles

3-year follow-up of the S1826 study confirms improved progression-free survival with nivolumab-AVD compared to brentuximab vedotin-AVD in advanced stage classic Hodgkin lymphoma

Free
Alex Herrera, Michael Leblanc, Sharon Castellino, Hongli Li, Sarah Rutherford, Andrew Evens, Kelly Davison, Susan Parsons, Sairah Ahmed, Carla Casulo, Nancy Bartlett, Joseph Tuscano, Matthew Mei, Brian Hess, Ryan Jacobs, Boyu Hu, Craig Moskowitz, Christopher Forlenza, Andrew Doan, Adam Lamble, David Hodgson, Anca Prica, Michael Knopp, Tricia Hernandez, Richard Little, Margaret Shipp, Michael Crump, Brad Kahl, John Leonard, Sonali Smith, Joo Song, Kara Kelly, Jonathan Friedberg
Journal: Blood
Blood (2025) 146 (Supplement 1): 151.
https://doi.org/10.1182/blood-2025-151
Published: 2025
Journal Articles

Circulating tumor DNA analyses of molecular tumor burden are superior to PET-assessed responses in patients with advanced stage classic Hodgkin lymphoma treated on SWOG S1826

Free
Julia Paczkowska, Marcin Kaszkowiak, Michael Leblanc, Chip Stewart, Alex Herrera, Juan Carlos Fernandez del Castillo, Sharon Castellino, Sarah Rutherford, Andrew Evens, Kelly Davison, Hongli Li, Donna Neuberg, Mark Murakami, Jasmine Makker, Brad Kahl, John Leonard, Nancy Bartlett, Sonali Smith, Joo Song, Kara Kelly, Gad Getz, Jonathan Friedberg, Margaret Shipp
Journal: Blood
Blood (2025) 146 (Supplement 1): 351.
https://doi.org/10.1182/blood-2025-351
Published: 2025
Journal Articles

Nuclear Expression of the Sox 11 Transcription Factor in Mantle Cell Lymphoma, and Cytoplasmic Expression in Follicular Lymphoma and Multiple Myeloma: Pathogenetic Implications.

Free
Michael E Williams, M.D., Sarah Rutherford, M.D., Yunjia Tang, M.D., John Cousar, M.D.
Journal: Blood
Blood (2009) 114 (22): 2925.
https://doi.org/10.1182/blood.V114.22.2925.2925
Published: 2009
Journal Articles

Targeting Angiogenesis in Mantle Cell Lymphoma: Clinical Efficacy and Correlative Studies of a Phase II Trial of RT-PEPC (Rituximab, Thalidomide and Metronomic Oral Chemotherapy with Prednisone, Etoposide, Procarbazine and Cyclophosphamide) in Relapsed/Refractory Disease.

Free
Jia Ruan, MD, PhD, Morton Coleman, MD, Richard R. Furman, MD, Patricia Glynn, Maureen Joyce, Jamie Ketas, Ken Cheung, PhD, Sarah Church, Tsiporah Shore, MD, Eric Feldman, MD, Sarah Rutherford, Elizabeth Hyjek, MD, PhD, Amy Chadburn, MD, Shahin Rafii, MD, John P. Leonard, MD
Journal: Blood
Blood (2006) 108 (11): 2751.
https://doi.org/10.1182/blood.V108.11.2751.2751
Published: 2006